Puymirat et al., 2017 - Google Patents
Clinical outcomes according to symptom presentation in patients with acute myocardial infarction: Results from the FAST‐MI 2010 registryPuymirat et al., 2017
View PDF- Document ID
- 11924605609355740205
- Author
- Puymirat E
- Aissaoui N
- Bonello L
- Cayla G
- Labèque J
- Nallet O
- Motreff P
- Varenne O
- Schiele F
- Ferrières J
- Simon T
- Danchin N
- FAST‐MI Investigators
- Publication year
- Publication venue
- Clinical Cardiology
External Links
Snippet
Background Atypical clinical presentation in acute myocardial infarction (AMI) patients is not uncommon; most studies suggest that it is associated with unfavorable prognosis. Hypothesis Long‐term clinical impact differs according to predominant symptom …
- 206010000891 Acute myocardial infarction 0 title abstract description 79
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Andrade et al. | Cryoablation or drug therapy for initial treatment of atrial fibrillation | |
Puymirat et al. | Clinical outcomes according to symptom presentation in patients with acute myocardial infarction: Results from the FAST‐MI 2010 registry | |
Banerjee et al. | Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project | |
Storey et al. | Platelet inhibition with ticagrelor 60 mg versus 90 mg twice daily in the PEGASUS-TIMI 54 trial | |
Schnyder et al. | Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial | |
Rubboli et al. | One‐year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry | |
Stroke Risk in Atrial Fibrillation Working Group | Independent predictors of stroke in patients with atrial fibrillation: a systematic review | |
Vemmos et al. | Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10‐year follow‐up study | |
Otsuka et al. | Hepatotoxicity and cutaneous reactions after antithyroid drug administration | |
Lip et al. | Atrial fibrillation diagnosis timing, ambulatory ECG monitoring utilization, and risk of recurrent stroke | |
Piedra et al. | Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis | |
Park et al. | Relationship of functional disability after a recent stroke with recurrent stroke risk | |
You | Novel oral anticoagulants versus warfarin therapy at various levels of anticoagulation control in atrial fibrillation—a cost-effectiveness analysis | |
Angerås et al. | Treatment pattern of contemporary dual antiplatelet therapies after acute coronary syndrome: a Swedish nationwide population-based cohort study | |
Zhang et al. | Relationship of left ventricular thrombus formation and adverse outcomes in acute anterior myocardial infarction in patients treated with primary percutaneous coronary intervention | |
Vavalle et al. | Prognostic significance of bleeding location and severity among patients with acute coronary syndromes | |
Dentali et al. | Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: a systematic review and meta-analysis of the literature | |
Barras et al. | Individualized compared with conventional dosing of enoxaparin | |
Li et al. | [Retracted] The Predictive Effect of Negative Psychological Emotions of Anxiety and Depression on the Poor Prognosis of CHD Patients with Stent Implantation and the Improvement of Clinical Intervention Measures | |
Lin et al. | Long-term cost-effectiveness of statin treatment for primary prevention of cardiovascular disease in the elderly | |
Mitchell et al. | Anticoagulant use in older persons at risk for falls: therapeutic dilemmas—a clinical review | |
Yamashita et al. | Safety and effectiveness of edoxaban in Japanese patients with nonvalvular atrial fibrillation: final report of a two‐year postmarketing surveillance study (ETNA‐AF‐Japan) | |
Parsons et al. | Coronary artery disease in the military patient | |
Habert | Minimizing bleeding risk in patients receiving direct oral anticoagulants for stroke prevention | |
Rankin et al. | Population‐level incidence and monitoring of adverse drug reactions with long‐term amiodarone therapy |